<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="drug-table.xslt"?><drug name = "ganciclovir inj VIAL">
<dose><value>5</value>
<value>2.5</value>
<value>1.25</value>
<value>0.625</value>
<value>6</value>
</dose>
<route><value>IV</value>
<value>IV </value>
</route>
<strength><value>500 mg</value>
</strength>
<frequency><value>Q12H</value>
<value>DAILY</value>
<value>THREE TIMES WEEKLY </value>
<value>FIVE TIMES WEEKLY</value>
</frequency>
<instruction><value>Administer post hemodialysis.</value>
</instruction>
<volume></volume>
<units><value>mg/kg</value>
</units>
<Population></Population>
<IndicationPRN></IndicationPRN>
<AdditionalNotes><value>CMV Infection: Induction Dose- continued for 14-21 days.</value>
<value>CMV Infection: Maintenance Dose following iduction dosage regimen OR prevention.</value>
<value>CrCl = 50 - 69 mL/min.</value>
<value>CrCl = 25 - 49 mL/min.</value>
<value>CrCl = 10 - 24 mL/min.</value>
<value>CrCl &amp;lt; 10 mL/min or hemodialysis.</value>
<value>CVVHD</value>
<value>CMV Infection: Maintenance Dose following iduction dosage regimen.</value>
</AdditionalNotes>
<BackgroundInformation><value>Treatment/Induction Dose</value>
<value>Prevention/Maintenance Dose</value>
</BackgroundInformation>
<PRNInformation></PRNInformation>
<AHSFormularyStatus><value>Formulary with Usage guidelines.</value>
</AHSFormularyStatus>
<AHFSName><value>Antivirals, Nucleosides and Nucleotides</value>
</AHFSName>
<HighAlert></HighAlert>
</drug>